Prematurity Clinical Trial
— MISAME-3Official title:
Effect of a Fortified Balanced Energy-Protein Supplement on Birth Outcome and Child Growth in Houndé District, Burkina Faso.
Verified date | March 2022 |
Source | University Ghent |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The 2016 WHO antenatal care guidelines stated that pregnant women in undernourished populations should receive fortified balanced energy-protein (BEP) supplements to reduce the risk of stillbirth and small-for-gestational-age birth. However, acceptable supplements and delivery channels must be determined for different contexts. The present proposal therefore will 1) perform a formative study to identify the most suitable (acceptability and utilization) BEP supplement for pregnant women in rural Burkina Faso (phase 1) and 2) evaluate the efficacy of this supplement to improve birth weight, fetal and infant growth (phase 2). The nutritional composition of the BEP supplement was established during an expert convening at the BMGF in September 2016. Private sector partners will prepare the supplements in the selected forms with the recommended nutrient composition.
Status | Completed |
Enrollment | 1788 |
Est. completion date | March 15, 2022 |
Est. primary completion date | March 15, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 15 Years to 40 Years |
Eligibility | Inclusion Criteria: - Participant age (15-40 years). - Pregnant as determined by a pregnancy test and confirmed by ultrasound. - Women who signed the informed consent form (in case of minors the parents or husband signs) Exclusion Criteria: - Women planning to leave the area before delivery. - Women who plan to deliver outside the area. - Pregnancies with a gestational age > 20 weeks at study inclusion. - Women with multi-fetal gestation (exclusion from analysis). - Women who are allergic to peanuts. |
Country | Name | City | State |
---|---|---|---|
Burkina Faso | Houndé district | Houndé | Tuy |
Lead Sponsor | Collaborator |
---|---|
University Ghent | AfricSanté, Burkina Faso, Bill and Melinda Gates Foundation, Harvard School of Public Health (HSPH), Institut de Recherche en Sciences de la Sante, Burkina Faso, International Food Policy Research Institute, University of California, Davis |
Burkina Faso,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Small-for-Gestational-age (SGA) | Incidence of Small-for-Gestational-age (SGA) defined as <10th centile of birthweight for gestational age standard, InterGrowth 21st reference. | within 72h after birth | |
Primary | Length-for-age Z-scores (LAZ) | Mean of Length-for-Age Z-scores (LAZ), WHO multi-country reference. | at 6 months (and 12 months on a subsample) | |
Secondary | Birth weight | within 72h after birth | ||
Secondary | Birth length | within 72h after birth | ||
Secondary | Chest circumference | within 72h after birth | ||
Secondary | Head circumference | within 72h after birth | ||
Secondary | Mid-upper arm circumference | within 72h after birth | ||
Secondary | Gestational age | at delivery | ||
Secondary | Preterm birth | Incidence of preterm birth at <37 weeks of gestation | at delivery | |
Secondary | Large-for-gestational age | Defined as a birth weight =90th centile intergrowth 21st reference | within 72h after birth | |
Secondary | Ponderal or Rohrer's index' | Defined as birth weight/birth length3 | within 72 hours after birth | |
Secondary | Fetal loss | Fetal death at <24 completed weeks of gestational age | during pregnancy | |
Secondary | Stillbirths | Fetal death at = 24 weeks gestational age | during pregnancy | |
Secondary | Neonatal mortality | (1) Early neonatal mortality: deaths between birth and = 7 days of life; (2) Neonatal mortality: deaths between birth and =28 days of life; (3) Late neonatal mortality deaths between >7 days and =28 days of life | between birth and = 28 days of life | |
Secondary | Prenatal weight gain | Weight change between study inclusion until just before delivery: total and trimester specific | between study inclusion until just before delivery | |
Secondary | Gestational weight change | Difference in maternal weight between maternal weight one month after delivery and maternal weight at study inclusion | between study inclusion until 1 month after delivery | |
Secondary | Probable and possible maternal postnatal depression | Measured using the 10-item Edinburgh postnatal depression scale. Probable depression is defined as EPDS>12. Possible depression is defined as EPDS>9 . | (1) at 2 months of child age; (2) at 6 months of child age | |
Secondary | Women's minimum and mean dietary diversity score | Measured biweekly using the 10 food group indicator as proposed by FAO. Minimum dietary diversity is defined as having consumed at least 5 food groups over the last 24 hours. | from study inclusion until delivery | |
Secondary | Maternal anemia | Hemoglobin concentration <11g/dL | at the third antenatal consultation | |
Secondary | Weight-for-Age Z-score | WAZ, calculated using the WHO growth reference | at 6 months of age | |
Secondary | Weight-for-Length Z-score | WLZ, calculated using the WHO growth reference | at 6 months of age | |
Secondary | Stunting | Length-for-Age Z-score (LAZ) <-2, calculated using the WHO growth reference | at 6 months of age | |
Secondary | Wasting | Weight-for-Length Z-score (WLZ) <-2, calculated using the WHO growth reference | at 6 months of age | |
Secondary | Underweight | Weight-for-Age Z-score (WAZ) <-2, calculated using the WHO growth reference | at 6 months of age | |
Secondary | Incidence of child wasting | over first 6 months of life | ||
Secondary | Child weight gain | Monthly change in child weight | over first 6 months of life | |
Secondary | Monthly change in LAZ | over first 6 months of life | ||
Secondary | Monthly change in WHZ | over first 6 months of life | ||
Secondary | Monthly change in WAZ | over first 6 months of life | ||
Secondary | Monthly change in head circumference | over first 6 months of life | ||
Secondary | Exclusive breastfeeding | Duration of exclusive breastfeeding | during the first 6 months of life | |
Secondary | Child mortality | between birth and 6 months of age | ||
Secondary | Child morbidity symptoms | Signs include fever, vomiting, diarrhea, cough, difficult breathing, running nose | over first 6 months of life | |
Secondary | Child anemia | Hemoglobin concentration <11g/dL | at 6 months of age | |
Secondary | Hemoglobin concentration | at 6 months of age | ||
Secondary | Infant body composition | Sub-sample | first 3 months of life | |
Secondary | Maternal body composition | Sub-sample | first 3 months after delivery | |
Secondary | Breast milk composition | Sub-sample | between 1-2 and 3-4 months | |
Secondary | Relative average telomere length | The umbilical cord blood will be analyzed to verify telomere length using qPCR on a sub-sample. Telomere lengths will be expressed as the ratio of telomere copy number to single-copy gene number (T/S) relative to the mean T/S ratio of the entire sample. | At birth |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03670732 -
CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure
|
N/A | |
Completed |
NCT05322161 -
Yoga in the NICU for Parents Study
|
N/A | |
Recruiting |
NCT04542096 -
Real Time Evaluation of Dynamic Changes of the Lungs During Respiratory Support of VLBW Neonates Using EIT
|
||
Recruiting |
NCT04911452 -
Creating a Calmer NICU: Optimizing Growth and Brain Development in Preterm Infants
|
N/A | |
Recruiting |
NCT02901652 -
NIPPV and nBiPAP Methods in Preterm Infants With Respiratory Distress Syndrome
|
N/A | |
Completed |
NCT02148965 -
Effects of Exercise During Pregnancy on Maternal and Child Health: a Randomized Clinical Trial
|
N/A | |
Terminated |
NCT02032511 -
Comparison of RAM Cannula Nasal Continuous Positive Airway Pressure Versus Infant Flow Nasal Continuous Positive Airway Pressure (NCPAP)
|
N/A | |
Completed |
NCT02273843 -
A Trial on Different Dosages of Vitamin D in Preterm Infants With Late-onset Sepsis
|
Phase 1 | |
Completed |
NCT01721629 -
Weaning of Nasal Continuous Positive Airway Pressure (CPAP) in Premature Infants
|
N/A | |
Terminated |
NCT01819532 -
Milking the Umbilical Cord Versus Immediate Clamping in Pre-term Infants < 33 Weeks
|
N/A | |
Completed |
NCT01478711 -
Comprehensive Clinical Decision Support (CDS) for the Primary Care of Premature Infants
|
N/A | |
Completed |
NCT01523769 -
Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants
|
N/A | |
Completed |
NCT00951860 -
Assessment of Autonomic Maturation in Neonatal Period and Early Neural Development From a Longitudinal Prospective Cohort
|
N/A | |
Completed |
NCT00787124 -
Transfusions and Nitric Oxide Level in Preterm Infants
|
||
Completed |
NCT00749008 -
Study of Generalized Movements for Early Prediction of Cerebral Palsy
|
N/A | |
Terminated |
NCT01208493 -
Dietary Protein in the Very-low-birth-weight Infant
|
N/A | |
Terminated |
NCT00486395 -
Will CPAP Reduce Length Of Respiratory Support In Premature Infants?
|
Phase 3 | |
Completed |
NCT00527956 -
Facilitation and Barriers to Breastfeeding in the NICU
|
N/A | |
Completed |
NCT03372590 -
NEO Rehab for Infants at Risk of Cerebral Palsy
|
N/A | |
Completed |
NCT00033917 -
Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial
|
Phase 3 |